0001581178 2026-07-31 2026-07-31 0001581178 1 2026-07-31 2026-07-31 0001581178 2 2026-07-31 2026-07-31 0001581178 3 2026-07-31 2026-07-31 0001581178 4 2026-07-31 2026-07-31 0001581178 5 2026-07-31 2026-07-31 0001581178 6 2026-07-31 2026-07-31 0001581178 7 2026-07-31 2026-07-31 iso4217:USD pure F-10 F-10 EX-FILING FEES 0001581178 EUPRAXIA PHARMACEUTICALS INC. N/A N/A 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 F-10 EUPRAXIA PHARMACEUTICALS INC. Equity Common shares, without par value true Equity Preferred shares, without par value true Debt Debt securities true Other Subscription receipts true Other Warrants true Other Units true false Unallocated (Universal) Shelf true 300000000.00 0.0001381 41430.00 300000000.00 41430.00 0.00 0.00 41430.00 There are being registered under this Registration Statement such indeterminate number of common shares, preferred shares, debt securities, warrants, subscription receipts and units of Eupraxia Pharmaceuticals Inc. (the "Registrant"), and a combination of such securities, separately or as units, as may be sold by the Registrant from time to time, which collectively, shall have an initial aggregate offering price not to exceed $300,000,000 (or its equivalent in any other currency used to denominate the securities). The maximum aggregate offering price is estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the U.S. Securities Act of 1933, as amended (the "Securities Act"). Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of common shares, preferred shares, debt securities, warrants, subscription receipts and units as may be issuable with respect to the securities being registered hereunder as a result of share splits, share dividends, or similar transactions. The proposed maximum initial offering price per security will be determined, from time to time, by the Registrant in connection with the sale of the securities under this Registration Statement.